Extremely powerful, high-force electric linear actuators: Mclennan and Creative Motion Control sign distribution agreement

Mclennan, the leading motion control component supplier and systems integrator has signed a distribution agreement with the USA-based electric linear actuator, roller screw and grooved roller bearing designer and manufacturer Creative Motion Control (CMC). Formed in 2002, and with a growing reputation for its innovative approach to motion engineering, CMC’s products are characterised by their Read more about Extremely powerful, high-force electric linear actuators: Mclennan and Creative Motion Control sign distribution agreement[…]

Eckert & Ziegler Signs Long-Term Supply Agreement with Sirtex Medical on Yttrium-90 for Treating Liver Cancer

Eckert & Ziegler AG (ISIN DE0005659700, TecDAX) and Sirtex Medical (Sirtex) have executed a long-term supply agreement for the use of EZAG’s Yttrium-90 in Sirtex SIR-Spheres® Y-90 resin microspheres for liver cancer. The arrangement has an initial term of five years and guarantees Eckert & Ziegler a substantial share of Sirtex’s rising global demand. It Read more about Eckert & Ziegler Signs Long-Term Supply Agreement with Sirtex Medical on Yttrium-90 for Treating Liver Cancer[…]

The renaissance of printed mail

Worried that printed mail has been completely replaced by communication in digital channels? Think again! Data from recent studies reveal a more nuanced picture. For advertisers, printed mail has advantages that digital communication can’t match and vice versa. Used together, these channels offer marketeers a variety of complementary tools to reach customers effectively and profitably. Read more about The renaissance of printed mail[…]

Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin

Eckert & Ziegler is proud to announce that it is expanding its production site in Berlin, Germany, with a new production facility for the contract manufacturing of radiopharmaceuticals. This new cGMP clean room suite with a total area of around 270 m² will be a 21 CFR 211 compliant, radiopharmaceutical manufacturing facility dedicated to late Read more about Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin[…]

EXTEDO to extend its EXTEDOpulse RIM software solution using Generis’s CARA™ foundational content & business process management platform

EXTEDO, a leading provider of regulatory information management (RIM) software and services today announced that they have selected Generis’s CARA™, a foundational platform for content and business process management, to build out and enhance its EXTEDOpulse RIM solution and support expanding its market beyond Life Sciences. Under the agreement, EXTEDO will become a leading Build Read more about EXTEDO to extend its EXTEDOpulse RIM software solution using Generis’s CARA™ foundational content & business process management platform[…]

The renaissance of printed mail

Worried that printed mail has been completely replaced by communication in digital channels? Think again! Data from recent studies reveal a more nuanced picture. For advertisers, printed mail has advantages that digital communication can’t match and vice versa. Used together, these channels offer marketeers a variety of complementary tools to reach customers effectively and profitably. Read more about The renaissance of printed mail[…]

Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in USA

Eckert & Ziegler is proud to announce that it is expanding its production site in Wilmington just north of Boston, Massachusetts of a new production facility for the contract manufacturing of radiopharmaceuticals. This new cGMP clean room suite will be a 21 CFR 211 compliant, radiopharmaceutical manufacturing facility dedicated to late stage investigational and commercial Read more about Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in USA[…]

RiMatrix Next Generation – the future platform for all IT scenarios

In the IT infrastructure platform RiMatrix Next Generation (NG), Rittal has created a new modular system for establishing data centres flexibly, reliably and fast. Based on an open platform architecture, customised solutions for any future IT scenario can be implemented anywhere in the world that are a safe investment – whether they are single rack Read more about RiMatrix Next Generation – the future platform for all IT scenarios[…]

Immatics Presents Preclinical Proof-of-Concept Data for TCR Bispecifics Program IMA401 Targeting MAGEA4/8

Immatics’ first TCR Bispecific program IMA401 delivers preclinical proof-of-concept demonstrating complete remissions of transplanted human tumors in mice and favorable CMC characteristics The IMA401 target, an HLA-A*02-bound peptide derived both from MAGEA4 and MAGEA8, shows >5-fold higher target peptide levels on cancer cells than a commonly used target peptide derived from MAGEA4 Immatics continues to Read more about Immatics Presents Preclinical Proof-of-Concept Data for TCR Bispecifics Program IMA401 Targeting MAGEA4/8[…]

Analytical Toolbox for Cell and Gene Therapy development

Gene therapies play an increasingly significant role in the future of medicine. Process development and quality testing are yet in the focus of the international authorities. Today, due to their specific characteristics as non self-replicative viral vectors, adeno-associated viruses (AAVs) are a safe approach for delivering the genes of interest. Innovative companies face analytical challenges Read more about Analytical Toolbox for Cell and Gene Therapy development[…]